Breaking News Instant updates and real-time market news.

CHE

Chemed

$292.26

-2.2 (-0.75%)

16:16
04/19/18
04/19
16:16
04/19/18
16:16

Chemed reports Q1 adjusted EPS $2.72, consensus $2.36

Reports Q1 revenue $439M, consensus $419.34M.

  • 20

    Apr

CHE Chemed
$292.26

-2.2 (-0.75%)

07/27/17
OPCO
07/27/17
NO CHANGE
Target $220
OPCO
Outperform
Chemed price target raised to $220 from $200 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Chemed to $220 from $200 following "very impressive" quarterly results. Furthermore, the analyst believes the end to the DoJ overhang would relieve the biggest overhang affecting the stock. Wiederhorn reiterates an Outperform rating on the shares.
08/28/17
KEYB
08/28/17
INITIATION
KEYB
Sector Weight
Chemed initiated with a Sector Weight at KeyBanc
KeyBanc analyst Jason Gurda initiated Chemed with a Sector Weight due to premium valuation and said he would wait for a pullback before getting involved.
10/31/17
RBCM
10/31/17
NO CHANGE
Target $232
RBCM
Sector Perform
Chemed price target raised to $232 from $209 at RBC Capital
RBC Capital analyst Frank Morgan raised his price target on Chemed to $232 following Q3 results that topped management expectations despite the hurricane related admission disruptions. Morgan says VITAS margin improvement was the result of an easy acuity comp, and the storm activity impact was immaterial because the admissions decline was mainly among the lower-margin short-stay patients. The analyst is also positive on the results and the management outlook for the company's Roto-Rooter segment, keeping his Sector Perform rating on Chemed.
02/15/18
OPCO
02/15/18
NO CHANGE
Target $275
OPCO
Outperform
Chemed price target raised to $275 from $270 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Chemed to $275 from $270 after the company reported a Q4 beat and issued "robust" FY2018 guidance. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

HKMPY

Hikma

$0.00

(0.00%)

14:47
09/19/18
09/19
14:47
09/19/18
14:47
Conference/Events
Hikma has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MS

Morgan Stanley

$49.09

1.22 (2.55%)

14:45
09/19/18
09/19
14:45
09/19/18
14:45
Options
Morgan Stanley call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 02

    Oct

FB

Facebook

$162.94

2.63 (1.64%)

14:42
09/19/18
09/19
14:42
09/19/18
14:42
Periodicals
Facebook user terms not yet in line with EU consumer laws, Reuters says »

Facebook may be slapped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

IPSEY

Ipsen

$0.00

(0.00%)

14:40
09/19/18
09/19
14:40
09/19/18
14:40
Conference/Events
Ipsen has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SIEN

Sientra

$23.85

-0.3 (-1.24%)

14:40
09/19/18
09/19
14:40
09/19/18
14:40
Hot Stocks
SEC charges Sientra, former CEO with misleading investors »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

14:35
09/19/18
09/19
14:35
09/19/18
14:35
General news
Fed Policy Outlook: by this time next week »

Fed Policy Outlook: by…

DRE

Duke Realty

$28.36

-0.35 (-1.22%)

14:29
09/19/18
09/19
14:29
09/19/18
14:29
Hot Stocks
Duke Realty VP Peter Harrington sells almost 17K shares »

Duke Realty VP Peter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXGBY

Hexagon AB

$0.00

(0.00%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Conference/Events
Hexagon AB management to meet with RBC Capital »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

WMB

Williams

$28.14

0.05 (0.18%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Hot Stocks
Williams requests FERC permission to place Atlantic Sunrise into full service »

Williams reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$4.93

0.675 (15.86%)

14:25
09/19/18
09/19
14:25
09/19/18
14:25
Options
Neptune Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$162.44

5.8 (3.70%)

14:18
09/19/18
09/19
14:18
09/19/18
14:18
Recommendations
Alibaba analyst commentary  »

Stifel still confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/19/18
09/19
14:17
09/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$169.33

-6.1 (-3.48%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Periodicals
Spotify accused of ' fostering a negative work culture for women,' Verge says »

Music streaming company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$162.49

5.85 (3.73%)

14:13
09/19/18
09/19
14:13
09/19/18
14:13
Periodicals
Alibaba no longer plans to bring 1M jobs to U.S. in wake of trade war, CNBC says »

Alibaba founder and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SAFM

Sanderson Farms

$100.90

-2.04 (-1.98%)

14:09
09/19/18
09/19
14:09
09/19/18
14:09
Hot Stocks
Sanderson Farms reports on impact to operations from Hurricane Florence »

Sanderson Farms reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 06

    Nov

14:08
09/19/18
09/19
14:08
09/19/18
14:08
Conference/Events
RBC Capital internet analyst to hold a luncheon »

Internet Analyst Mahaney…

14:06
09/19/18
09/19
14:06
09/19/18
14:06
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

14:04
09/19/18
09/19
14:04
09/19/18
14:04
Conference/Events
RBC Capital biotech analysts to hold a group breakfast »

Biotech Gene Therapy…

CZR

Caesars

$10.90

0.1 (0.93%)

14:00
09/19/18
09/19
14:00
09/19/18
14:00
Options
Caesars option volume is 2X daily average and calls lead puts 10:1 »

Caesars option volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

13:51
09/19/18
09/19
13:51
09/19/18
13:51
Initiation
Elanco, Eli Lilly initiated  »

Elanco initiated with a…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

LFUS

Littelfuse

$204.06

-9.68 (-4.53%)

13:41
09/19/18
09/19
13:41
09/19/18
13:41
Recommendations
Littelfuse analyst commentary  »

Use weakness to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

MRK

Merck

$70.16

-0.26 (-0.37%)

, BMY

Bristol-Myers

$60.93

-0.55 (-0.89%)

13:36
09/19/18
09/19
13:36
09/19/18
13:36
Periodicals
Merck cuts key cancer drug price for China launch, Caixin reports »

Merck (MRK) will cut the…

MRK

Merck

$70.16

-0.26 (-0.37%)

BMY

Bristol-Myers

$60.93

-0.55 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

GLUU

Glu Mobile

$7.30

-0.285 (-3.76%)

13:35
09/19/18
09/19
13:35
09/19/18
13:35
Options
Glu Mobile put volume heavy and directionally bearish »

Bearish flow noted in Glu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$23.75

0.5 (2.15%)

, TLRY

Tilray

$227.50

72.51 (46.78%)

13:34
09/19/18
09/19
13:34
09/19/18
13:34
Periodicals
Revlon could be set for short squeeze similar to Tilray's, Mox Reports says »

Mox Reports, which has…

REV

Revlon

$23.75

0.5 (2.15%)

TLRY

Tilray

$227.50

72.51 (46.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.